Monitoring brain activity during withdrawal of life support
Official title: Neurologic Physiology After Removal of Therapy (NeuPaRT): Pilot Multicentre Feasibility Study
Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT05306327 · Data updated 2026-11-12
This study is testing how brain activity changes when life support is stopped to help understand the timing of death and improve trust in organ donation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Academic / other |
| Locations | 5 sites (Calgary, Alberta and 4 other locations) |
| Status | Recruiting |
| Started | October 18, 2022 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT05306327 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are undergoing planned withdrawal of life-sustaining measures and are expected to die within 24 hours.
✕Probably not a fit
Patients who are already declared brain dead or those with conditions that prevent neurologic monitoring will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the timing of brain function cessation in relation to heart function cessation by using electroencephalography (EEG) in patients who are undergoing withdrawal of life-sustaining measures in an intensive care unit. It seeks to provide evidence regarding the neurologic determination of death, particularly in the context of organ donation after circulatory determination of death. By monitoring electrical brain activity, the study will clarify the relationship between brain and heart activity during the dying process, addressing concerns about the current practices in organ donation. The findings could enhance the understanding of death determination and improve trust in the organ donation process.
Why it matters
Potential benefit: If successful, this study could provide critical insights that enhance the ethical framework and trust surrounding organ donation practices.
How similar studies have gone: While the approach of monitoring brain activity during the dying process is novel, similar studies have not been widely conducted, making this an important and potentially groundbreaking investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Plan for the withdrawal of life sustaining measures (WLSM) 3. Attending physician anticipates patient will die within 24 hours of the withdrawal of life sustaining measures 4. Patient has an indwelling arterial cannula for monitoring blood pressure Exclusion Criteria: 1. Brain death or plan for Neurologic Determination of Death (NDD) 2. Injuries that anatomically preclude the use of neurologic monitoring
Where it's running
-
University of Calgary Foothills Campus
Calgary, Alberta, Canada Recruiting -
Kingston Health Sciences Centre
Kingston, Ontario, Canada Recruiting -
London Health Sciences Centre
London, Ontario, Canada Recruiting -
Ottawa Hospital
Ottawa, Ontario, Canada Recruiting -
Centre hospitalier de l'Université de Montréal,
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Teneille Gofton, MD MSc FRCPC — London Health Sciences Centre
- Study coordinator: Teneille Gofton
- Email: teneille.gofton@lhsc.on.ca
- Phone: 519-663-2911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Faster brain stimulation for PTSD and depression
This pilot study tests a quicker brain stimulation schedule (accelerated iTBS) to see if it’s doable, safe, and tolerable for adults with PTSD and major depression.
-
Bladder Management and Quality of Life in Young Adults with Spina Bifida
This study asks teens and young adults with spina bifida how different bladder care methods affect their daily life and happiness.
-
What factors predict delayed behavior problems in children after procedural sedation
This study will test which factors make children aged 1–17 more likely to have delayed behavior problems (such as sleep trouble, anxiety, or aggression) after procedural sedation in emergency departments and dental clinics.
-
Gentamicin dosing in neonates: checking if extended-interval dosing still works
This study checks whether extended-interval gentamicin dosing in newborns up to 7 days old still achieves safe and effective drug levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.